Related Experiment Video
Updated: Jun 26, 2026

07:44
In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
3.0K
Classification of diabetic maculopathy based on optical coherence tomography images using a Vision Transformer model.
Liwei Cai1, Chi Wen2, Jingwen Jiang3
1Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
BMJ Open Ophthalmology
|December 22, 2023
Summary
A new Vision Transformer model accurately detects diabetic maculopathy (DM) stages using optical coherence tomography (OCT) images. This AI tool aids in preliminary screening, identifying patients needing further diagnosis and timely treatment for better visual outcomes.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Diabetic maculopathy (DM) is a leading cause of vision loss.
- Accurate staging of DM is crucial for timely intervention and prognosis.
- Optical coherence tomography (OCT) is a key imaging modality for DM assessment.
Purpose of the Study:
- To develop and evaluate a Vision Transformer (ViT) deep learning model.
- To detect and classify different stages of diabetic maculopathy using OCT images.
- To assess the model's performance in differentiating early diabetic macular edema, advanced DME, severe DME, and atrophic maculopathy.
Main Methods:
- A dataset of 3319 retrospective OCT images from DM patients was curated.
- Images were randomly split into training (70%) and validation (30%) sets.
- A deep learning model based on the Vision Transformer architecture was trained for DM stage detection.
Main Results:
- The ViT model achieved an overall accuracy of 82.00% and an F1 score of 83.11%.
- Area under the curve (AUC) for overall detection was 0.96.
- Specific AUCs for early DME, advanced DME, severe DME, and atrophic maculopathy were 0.96, 0.95, 0.87, and 0.98, respectively.
Conclusions:
- The developed Vision Transformer model demonstrates high accuracy in grading diabetic maculopathy from OCT images.
- This AI tool can assist in preliminary screening, identifying high-risk patients for further evaluation.
- The study highlights the potential of AI in supporting clinical decision-making for diabetic maculopathy management.

